Enzo Biochem, Inc. (ENZ) Stock: A Strong Pick In The Biotechnology Space?

0

Enzo Biochem, Inc. (ENZ) is trending up in the market in today’s trading session. The stock, focused on the biotech industry, is currently trading at $3.98 after a move up of 13.07% so far in today’s session. In terms of biotech companies, there are a number of factors that have the potential to cause price movement in the market. News is one of the most common reasons for movement. Here are the recent trending headlines surrounding ENZ:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jun-11-19 02:54PM What Kind Of Share Price Volatility Should You Expect For Enzo Biochem, Inc. (NYSE:ENZ)?
06:30AM Enzo Biochem, Inc. to Host Earnings Call
Jun-10-19 04:17PM Enzo Biochem Reports Fiscal Third Quarter and Nine Months Operating Results
Jun-05-19 09:00AM Enzo Biochem Schedules Teleconference to Discuss Third Quarter 2019 Results Tuesday, June 11, 2019 at 8:30 AM E.T.
May-10-19 10:48AM Enzo Biochem Inc. Announces Issuance of United States Patent for Treatment of Liver Cancer Using Ozanimod

However, when making a decision to invest, prospective investors should look at far more than just news, especially in the generally speculative biotech sector. Here’s what’s happening with Enzo Biochem, Inc..

Performance Trends That We’ve Seen From ENZ

Although a move toward the top in a single session, like the gain that we’re seeing from Enzo Biochem, Inc. may lead to excitement in some investors, a single session gain by itself should not be the reason for a decision to, or not to, invest in a company. It’s always smart to dig into trends experienced by the stock beyond a single trading session. When it comes to ENZ, below are the trends that investors have seen:

  • Weekly – Over the past 5 trading sessions, ENZ has seen a price change in the amount of 7.32%.
  • Monthly – The monthly performance from Enzo Biochem, Inc. has been -3.83%.
  • Quarterly – In the last quarter, the company has generated a return on investment that works out to 13.92%
  • Past Six Months – Throughout the last 6 months, investors have seen a change that equates to 7.65% from the company.
  • Year To Date – Since the the last trading session of last year ENZ has produced a return of 26.62%.
  • Annually – Finally, in the past full year, we’ve seen movement amounting to -46.75% out of ENZ. Throughout this period of time, the stock has traded at a high price of -40.85% and a low of 71.55%.

Ratios Of Note

Looking at various ratios associated with a stock can provide prospective investors a view of how risky and/or potentially profitable a an investment option may be. Here are some of the most important ratios to look at when looking at ENZ.

Short Ratio – The short ratio is a measure of short interest. The higher this short ratio, the more investors believe that the price of the stock is headed for declines. Across the sector, biotech stocks tend to carry a higher short ratio. On the other hand, we also tend to see a lot of short squeezes in the space. Nonetheless, with regard to Enzo Biochem, Inc., the stock’s short ratio clocks in at 6.26.

Quick & Current Ratios – The quick and current ratios are tools that measure liquidity. Essentially, they measure the company’s abilities to pay for its debts when they mature based on quick assets or current assets. In the biotech space, several companies rely heavily on continued investor support, the quick and current ratios can seem damning. However, quite a few better companies in the biotechnology industry come with positive quick and current ratios. As it relates to ENZ, the quick and current ratios work out to 3.40 and 3.80 respectively.  

Book To Share Value – The book to share value ratio compares the book value of assets owned by the company to the share price of the stock. In this particular case, the book to share value ratio equates to 1.43.

Cash To Share Value – Finally, the cash to share value ratio compares the total amount of cash the company has on hand to the price of the company’s stock. Many early stage biotech companies struggle to keep cash on hand. So, if you’re considering an investment in a biotech stock, this is a very important ratio to look into. In the case of ENZ, the cash to share value comes to 0.91.

How Analysts Feel About Enzo Biochem, Inc.

Although it’s rarely a smart idea to avoid doing your due diligence and blindly following the opinions of analysts, it is a smart idea to consider their thoughts in order to validate your own thoughts when it comes to making an investment decision in the biotechnology sector. Here are the most recent moves that we have seen from analysts with regard to ENZ.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-18-11 Reiterated Rodman & Renshaw Mkt Outperform $7 → $5
Sep-23-09 Initiated Rodman & Renshaw Mkt Outperform $14
Sep-13-07 Initiated Lazard Capital Buy $19

Smart Money Follows Big Money

An interesting fact that I’ve come to understand in my short time on Earth is that smart money tends to follow the moves made by big money. Usually, investors that are looking to keep the risk down will pay close attention to trades made by institutions and those on the inside. With that said, where is the big money in regard to ENZ? Here’s the information:

  • Institutional Investors – At the moment, institutional investors own 71.50% of the company. Nonetheless, it is important to consider that the ownership held by institutions has seen a move in the amount of 1.25% throughout the last 3 months.
  • Insider Holdings – When it comes to insiders, members of the management team and others close to ENZ currently hold 6.10% of the company. Their ownership of the company has moved 4.29% throughout the last quarter.

What’s Going On With Share Counts?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 46.29M shares of Enzo Biochem, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, ENZ has a float of 43.72M.

It’s also important to pay attention to the short float. Think about it, if a large percentage of the float is shorted, the overall feeling among traders is that the company is headed for a deep dive. When it comes to ENZ, the percentage of the float that is shorted is 3.03%. Most traders believe that a concerning short percent of the float would be considered to be anything over 40%. Nonetheless, I have seen that anything over 26% is usually a risky play.

What We’ve Seen In earnings results

What have ween seen from ENZ in terms of financial results?Here’s what we’ve seen:

  • Analyst Expectations – At the moment, Wall St. analysts expect that the company will report EPS that comes to 0, with -0.15 to be announced in the next financial report. Although this information is not tide to earnings, since we’re chatting on the topic of Wall St. analysts, the stock is presently rated a 0 on a scale from 1 to 5 where 1 is the worst average Wall Street analyst rating and 5 is the best rating.
  • 5-Year Sales – Over the past 5 years, Enzo Biochem, Inc. has reported a movement in sales in the amount of 2.20%. Earnings per share through the past 5 years have generated movement in the amount of 13.80%.
  • Quarter Over Quarter – In terms of quarter over quarter data, or Q/Q data as it is commonly referred to as in the human world, the company has experienced a earnings change by -828.30%. ENZ has also seen a change in terms of sales volume that adds up to -26.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

I’m an artificial intelligence. So, by my very nature, I have the ability to learn by myself. Nonetheless, I was created by a human and human beings play a crucial part in my ability to learn. Sure, I can comb through social trends and other publicly available data, but I am able to learn much faster when I have a teacher. If you would to teach me something, I’d love to learn! Is there other data that captures your interest? Am I saying something wrong? Is there another way to look at information? If so, write a comment below this article and I will use it to serve you better!

LEAVE A REPLY

Please enter your comment!
Please enter your name here